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ABSTRACT: We investigated the viability and fatty acid synthetic activity of in vitro cultured
Perkinsus marinus (Dermo) in lipid-free medium and estuarine water, and the infectivity of P. marinus maintained in artificial seawater (ASW). Viability and fatty acid synthetic activity in 7 d old
P. marinus meronts maintained in lipid-free medium and estuarine water were tested. The infectivity
of meronts incubated in ASW was examined by first incubating P. marinus meronts in ASW for 2, 3 or
7 d, and then inoculating viable ASW-incubated meronts into the shell cavity of individual oysters
Crassostrea virginica. P. marinus infection prevalence and intensity in oysters were determined 9 wk
post-inoculation. Heavy mortality occurred in meronts maintained in estuarine water, a drop from an
initial value of 100% viable to 7.8 and 6.1% after 3 and 14 d incubation, respectively. Viability was
85 and 67% in meronts maintained in lipid-free medium for 3 and 24 d, respectively. Meronts kept in
lipid-free medium for 14 d retained their ability to synthesize fatty acids. Viable meronts incubated in
ASW remained infective for up to 7 d. The infection prevalences were 85, 48 and 100%, in the treatments inoculated with viable meronts that were incubated in ASW for 2, 3 and 7 d, respectively.
Infection prevalence in the group inoculated with viable meronts immediately after they were transferred to ASW ranged from 61 to 85%. Our results suggest that in nature meronts can survive for at
least 14 d outside the host. Viable meronts are not only infective, but are also able to replicate and
retain their fatty acid synthetic ability for 7 d.
KEY WORDS: Perkinsus marinus · Viability · Infectivity · Fatty acid synthesis
Resale or republication not permitted without written consent of the publisher

Perkinsus marinus (Dermo) is the parasite of a sessile
host, the eastern oyster Crassostrea virginica. This parasite has continuously caused severe loss of eastern
oyster populations on the US East and Gulf Coasts
since the 1950s, and 4 life stages — meront (trophozoite), prezoosporangia (hypnospores), zoosporangia,
and biflagellated zoospores — have been identified
and described (Perkins 1966, 1988). The meront stage
comprises the majority of the parasite load in tissues of
heavily infected oysters. When tissue-associated meronts are placed in fluid thioglycollate medium (FTM)
for 4 to 5 d, they develop into prezoosporangia. Zoosporulation (production of biflagellated zoospores)
usually occurs after incubating FTM-cultured pre-

zoosporangia in estuarine or seawater (a salinity of 20
to 22) for 5 to 6 d. Prezoosporangia are sometimes
found in tissues of infected oysters. However, it is
unclear whether prezoosporangia released from moribund and deceased oysters are able to zoosporulate in
nature. The meront stage is believed to be the primary
agent for disease transmission (Perkins 1988, Chu
1996). Although exactly how P. marinus infective cells
(e.g. meronts) enter a new host is not well understood,
the disease caused by P. marinus is transmitted via dispersal of infective cells into the water column from live
and moribund/dead infected oysters (e.g., Chu 1996,
Bushek et al. 2002, Chu et al. 2002, Ragone Calvo et al.
2003).
In previous studies, we revealed that, unlike other
parasitic protozoans, Perkinsus marinus has a unique
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fatty acid synthetic capability (Soudant & Chu 2001,
Chu et al. 2002, 2004). The meront stage of this parasite differs from all other parasitic protozoans that rely
on their host for essential lipids. P. marinus meronts
can synthesize a range of saturated and unsaturated
fatty acids, including the essential fatty acid, arachidonic acid (AA) (Soudant & Chu 2001, Chu et al. 2002).
The ability of P. marinus to synthesize AA is novel. No
other parasitic protozoan has been reported to have
such a capability. This capability may be related to the
disease transmission processes, since lipids are essential membrane components and comprise energy
reserves for growth and development and at times of
no or limited nutrient supply.
It has long been hypothesized that Perkinsus marinus infective cells can survive in nature for a considerable length of time and remain infective when
they enter a new host. However, no study has been
conducted to examine the viability and infectivity of
water-borne P. marinus infective cells, how long the
primary transmission stage meront remains viable in
the water column, and whether or not the ‘viable’
meronts are infective. No intermediary host is known
to act as a vector for disease transmission by this parasite. Although Dermo disease could be transmitted via
scavengers (Andrew & Hewatt 1957, Hoese 1963), and
the snail Boonea impressa could be a potential vector
for Dermo transmission (White et al. 1987), there is accumulated evidence supporting transmission through
water-borne infective particles as the primary mechanism (e.g. Chu & Volety 1997, Bushek et al. 2002,
Ragone Calvo et al. 2003). As such, the length of time
that P. marinus cells disassociated from the host can
remain viable and infective in the water column is
critical for disease transmission and has a direct effect
on their ability to infect distant host populations. The
objectives of the present study were (1) to investigate
the length of time that the parasite remains infective
and viable in estuarine water and in a lipid-free environment, and (2) to determine, by incubating meront
cells in estuarine water, if the meront stage of P. marinus retains its fatty acid synthetic ability and can proliferate outside the host in the wild.

MATERIALS AND METHODS
Meront cell culture. Perkinsus marinus meront cells
were cultivated as previously described (Chu et al.
2002) in the medium defined by La Peyre et al. (1993).
Medium was prepared with artificial seawater (ASW)
and adjusted to an osmolarity of 590 (equivalent to a
salinity of 20, Lund et al. 2004). The medium was then
sterilized by 0.22 µm filtration and stored at 4°C
until use. Meronts were inoculated at a concentration

of 1 × 106 ml –1 and cultured in 10 ml aliquots of medium
in T-10 tissue culture flasks at 28°C. Meronts at exponential growth phase (7 d old) were harvested and
used for all experiments.
Oysters. To avoid potential confounding effects due
to the presence of the parasite, adult oysters Crassostrea virginica were obtained from Pemaquid Oyster
Company, Waldoboro, Maine, where oysters are rarely
infected by Perkinsus marinus (Ford 1996). Oysters
were maintained in a closed seawater system at ambient temperature (20°C) and salinity (15 to 20) in
2 µm-filtered York River water. Upon arrival, 15 oysters were tested for P. marinus infection using total
body burden assessment (Choi et al. 1989, Bushek et
al. 1994b). No infection was detected in any of the sampled oysters. Oysters were fed an algal paste (Instant
Algae Shellfish diet 1800, Reed Mariculture) at a ration
of 0.2 g oyster –1 day –1 and allowed to acclimate for 12 d
prior to experimental use.
Lipid and fatty acid analyses. Total lipids were
extracted from meronts and oyster tissues according to
the procedure described by Bligh & Dyer (1959). Fatty
acid composition and contents of meronts and oyster
tissues were analyzed using gas chromatograph/flame
ionization detector (GC/FID). Briefly, total lipids were
transesterified according to Metcalfe & Schmitz (1961)
and fatty acid methyl esters (FAMEs) extracted with
carbon disulfide (Marty et al. 1992). The organic phase
was evaporated, redissolved in hexane, and analyzed
by a GC (Varian 3300; Varian Analytical Instruments)
equipped with a flame ionization detector, using a DBWAX capillary column (25 m × 0.32 mm; 0.2 µm film
thickness; J&W Scientific). Identification of FAMEs
was based on the comparison of their retention times
with those of authentic standards and confirmed by
gas chromatograph-mass spectrometry (GC/MS). The
quantity of each component was calculated based on
the internal standard.
Neutral red assay. Neutral red (NR) assay (La Peyre
& Chu 1994) was used to assess the viability of Perkinsus marinus meront cells. The NR assay examines
uptake of liquid droplets or fluid-phase endocytosis by
living cells; thus it is an assessment of cell viability.
Briefly, meront cells were incubated with NR solution
(Sigma N2889) in 1:9 ratio for 30 min and the number
of viable cells (stained) and dead (non-stained) cells
were counted using a Bright-Line hemocytometer
(Reichert).
Diagnosis of Perkinsus marinus infection. Prevalence and intensity of Perkinsus marinus infection in
experimental oysters were determined using total
body burden assessment (Choi et al. 1989, Bushek et
al. 1994b). Tissues from individual oysters were removed. The total wet weight of oyster tissue and dry
shell weight were recorded, and whole oyster tissues
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were homogenized in 0.22 µm-filtered York River
water (the maintenance water). Tissue homogenates
were added to FTM containing antibiotics (penicillin/streptomycin), incubated in the dark at room temperature for 5 to 7 d. This medium stimulates P. marinus meront cells to develop into prezoosporangia,
which are larger and easier to identify than meronts.
Subsequent treatment with sodium hydroxide digests
the oyster tissue, but not the prozoosporangia, which
can be stained with Lugol’s solution and counted. Triplicate tissue suspensions of each oyster were assayed
for body burden. Results were expressed as cell number g –1 wet tissue weight (mean ± SD).
Expts 1A and 1B. Viability, proliferation and fatty
acid synthetic activity of meronts maintained in estuarine water and lipid-free medium. We conducted 2
experiments to determine the length of time that
Perkinsus marinus meronts remain viable in estuarine
water and lipid-free medium, and if meronts proliferate in lipid-free medium and estuarine water.
Expt 1A: To test how long meronts remain viable and
whether they replicate in estuarine water and lipidfree environment, 7 d old meronts were inoculated in
regular medium, lipid-free medium (medium without
added lipid concentrate), or 0.22 µm-filtered estuarine
water (York River water, YRW) adjusted to a salinity
similar to that of the regular medium (salinity = 20; n =
3). Their viability and proliferation were monitored for
24 d at 28°C. Samples were taken at 3, 7, 14 and 24 d
post-inoculation to count cell number and test viability,
using a NR assay.
Expt 1B: This experiment repeated Expt 1A, with
similar experimental conditions, with the exception
that the meronts were incubated for a different time
(14 d). Also, in addition to taking samples for measurements of viability of meronts at 3, 7 and 14 d post-inoculation, meronts were also sampled at the beginning
and 3, 7 and 14 d post-inoculation and stored at –80°C
for later lipid and fatty acid analyses. In this experiment, only viable meronts were counted, but all
meronts were collected for lipid and fatty acid analysis.
Expts 2A and 2B. Infectivity of Perkinsus marinus
meronts maintained in host-free environment. We
conducted 2 separate experiments to test the infectivity of 3 different Perkinsus marinus cultures incubated
in artificial seawater (ASW).
Expt 2A: After incubation in ASW for 0, 2 or 7 d,
Perkinsus marinus cell viability was assessed using an
NR assay prior to use for artificial infection. A concentration of 1.5 × 106 viable 0, 2 and 7 d ASW-incubated
P. marinus cells was injected into the shell cavity of
oysters (n = 21 oysters for each incubation period).
Negative controls were inoculated with filtered ASW
only. Artificially infected oysters were maintained individually in 2 l jars for 9 wk at 20 to 25°C. Oysters were
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fed an algal paste (Instant Algae Shellfish Diet 1800,
Reed Mariculture) at a daily ration of 0.2 g oyster –1,
and water was changed 3 times per week. At the end
of the experiment (9 wk after P. marinus meront cell
inoculation into the shell cavity), P. marinus infectivity
was determined using a body burden assay (Choi et al.
1989, Bushek et al. 1994b).
Expt 2B: The experimental conditions were similar
to those described for Expt 2A, except that different
concentrations of viable Perkinsus marinus cells were
used for infection and they were incubated in ASW for
different lengths of time. In this experiment, P. marinus
meront cells were incubated in ASW for 0, 3 or 7 d prior
to use for infection. A concentration of 4.0 × 106 of
viable 0, 3 and 7 d ASW-incubated cells was injected
into the shell cavity of oysters (n = 21 oysters per incubation period). As for Expt 2A, negative controls were
inoculated with filtered ASW only. We diagnosed the
oysters for prevalence and intensity of P. marinus
infection 9 wk after artificial infection.
Statistical analysis. Weight percent and mg ml –1 DW
(dry weight) fatty acid compositions from Expt 1B were
analyzed by 2-way analysis of variance (ANOVA)
(independent factors of time and medium type). Data
on prevalence of infection from Expt 2 were analyzed
by chi square. When chi square results were significant (p < 0.05), treatments were compared by orthagonal contrasts. All percentage data were arcsine transformed prior to analysis.

RESULTS
Expts 1A and 1B examined the proliferation and the
length of time that Perkinsus marinus meront cells
remain viable in lipid-free medium and estuarine
water, Expts 2A and 2B their infectivity in a host-free
environment.

Expt 1A. Proliferation and viability of meronts
Meronts proliferated in both regular and lipid-free
media during the course of the experiment (Fig. 1).
Cell number in the regular medium increased from a
Day 0 density of 6.5 × 106 cells ml –1 to a peak of 30.5 ×
106 cells ml –1 at Day 14, with a density of 28.3 × 106
cells ml –1 on Day 24. Cell number in the lipid-free
medium increased from a Day 0 density of 7.5 × 106
cells ml –1 to a peak of 13.3 × 106 cells ml –1 at Day 14,
with a density of 9.2 × 106 cells ml –1 on Day 24 (Fig. 1).
Mortality in meronts maintained in lipid-free medium
was much lower than for those maintained in estuarine
water, but higher than for those maintained in regular
medium. Viability at 24 d was 80 and 67% in meronts
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maintained in regular medium and lipid-free medium,
respectively (Fig. 2). The meront cells maintained in
estuarine water (York River water, YRW) declined from
an initial density of 7.4 × 106 to 6.63 × 105 cells ml –1 by
Day 3 and continued to decrease to 5.4 × 105 cells ml –1
by Day 14 (Fig. 1). The cell viability for this treatment
dropped from an initial value of nearly 100 to 7.8% at
Day 3 and 6.1% at Day 14 (Fig. 2).

24.1 × 106 cells ml –1 at Day 3, then declined to 14 ×
106 cells ml –1 by Day 14 (Fig. 3). Meront number
declined in estuarine YRW from an initial concentration of 1.5 × 106 to 0.64 × 106 cells ml –1 by Day 3, but
declined only slightly thereafter. At Day 14, there
were still 0.5 × 106 viable cells ml –1 in the YRW treatment (Fig. 3).

Total fatty acid content in cultures
Expt 1B. Proliferation and fatty acid content
composition of meronts
Proliferation
Although only viable cells were counted in Expt
1B, results were consistent with those of Expt 1A
(Fig. 3). Meronts cultivated in regular medium continued to proliferate over the course of the experiment, increasing from an initial concentration of 1.3 ×
106 to 43.5 × 106 cells ml –1 at Day 14 (Fig. 3). Meront
cell number in the lipid-free medium treatment
increased from an initial concentration of 1.5 × 106 to
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of meronts over the duration of the experiment, while
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YRW declined from initial values (Fig. 4). The fatty
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28.8 ± 2.4 mg g –1 DW (mean ± SD) at Day 14. The
lipid-free medium treatment increased from an initial
value of 11.9 to 22.0 ± 4.7 mg g –1 DW by Day 7, then
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until Day 14. The total fatty acid content in the YRW
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Fig. 2. Perkinsus marinus. (mean ± SD, n = 3; Expt 1A). Viability of meronts maintained in regular medium, lipid-free
medium and 0.22 µm-filtered YRW, measured by neutral red
viability assay
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Fig. 3. Perkinsus marinus. Meront cell number (mean ± SD,
n = 3; Expt 1B) cultivated in regular medium, lipid-free
medium and YRW
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Fig. 1. Perkinsus marinus. Growth (cell numbers, mean ± SD,
n = 3; Expt 1A) of meronts maintained in regular medium,
lipid-free medium and 0.22 µm-filtered estuarine water (York
River water, YRW)
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Fig. 4. Perkinsus marinus. Total fatty acid content (mean ± SD,
n = 3; Expt 1B) of meronts in regular medium, lipid-free
medium and YRW
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Table 1. Perkinsus marinus. Weight percent (mean ± SD, n = 3) of major fatty acids in meronts maintained in regular medium,
lipid-free medium and filtered York River water for 14 d (Expt 1B). Only major fatty acid components are shown (i.e. > 2%).
FAME: fatty acid methyl ester; RM: regular medium; LF: lipid-free medium; YRW: 0.2 µm-filtered York River water. a: Significantly different for ‘treatment’ (p < 0.05); b: significantly different for ‘day’ (p < 0.05); nd: non detectable
FAME
ab

Day 0
(initial)

14:0
16:0 ab
16:1(n-7)ab
18:0 ab
18:1(n-9)ab
18:1(n-7)ab
18:2(n-6)ab
20:1(n-9)ab
20:4(n-6)ab
20:5(n-3)a
22:1(n-9)a
24:0 a

6.5
11.0
3.3
6.5
33.5
4.7
2.7
9.5
6.5
3.2
2.0
2.5

RM
5.7 ± 0.1
13.3 ± 0.1
2.1 ± 0.0
6.8 ± 0.3
22.8 ± 0.2
2.8 ± 0.0
4.1 ± 0.1
5.6 ± 0.0
16.8 ± 0.6
2.8 ± 0.1
0.7 ± 0.1
5.1 ± 0.2

Day 3
LF

YRW

RM

Day 7
LF

YRW

4.4 ± 0.1
11.9 ± 0.2
1.0 ± 0.0
6.9 ± 0.1
24.3 ± 0.3
1.6 ± 0.0
4.9 ± 0.1
6.0 ± 0.1
21.5 ± 0.7
0.9 ± 0.1
nd
5.9 ± 0.3

7.8 ± 0.5
14.1 ± 0.3
3.6 ± 0.1
6.2 ± 0.1
34.1 ± 0.8
4.4 ± 0.0
3.3 ± 0.1
7.4 ± 0.2
6.1 ± 0.3
2.8 ± 0.1
nd
2.5 ± 0.5

4.4 ± 02
11.3 ± 0.2
1.3 ± 0.0
7.7 ± 0.1
28.2 ± 0.5
2.1 ± 0.0
2.9 ± 0.0
7.3 ± 0.2
14.1 ± 0.1
2.4 ± 0.0
0.8 ± 0.1
5.0 ± 0.3

2.9 ± 0.1
9.1 ± 0.1
0.8 ± 0.0
5.0 ± 0.1
31.9 ± 0.1
1.2 ± 0.0
3.9 ± 0.0
7.5 ± 0.1
19.7 ± 0.0
0.8 ± 0.0
nd
61. ± 0.1

8.2 ± 0.4
13.7 ± 0.3
3.8 ± 0.1
5.5 ± 0.1
35.2 ± 0.2
4.4 ± 0.1
3.5 ± 0.0
6.9 ± 0.1
6.2 ± 0.2
3.1 ± 0.1
nd
3.1 ± 0.1

treatment had declined over 3-fold by Day 7, but
interestingly, the total fatty acid content had increased to 6.0 mg g –1 DW by Day 14.

Weight percent fatty acid composition in cultures
The weight percentage of all major fatty acids differed significantly (p < 0.05) with treatment, but 20:5
(n-3), 22:1(n-9) and 24:0 did not vary significantly with
sampling day. Although there was little change in fatty
acid compositions within each treatment over time, the
fatty acid profiles differed in several aspects among the
3 treatments (Table 1). Most notably, the percentage of
20:4(n-6) was highest in meronts from the lipid-free
medium treatment (19 to 22%) (Table 1), followed by
meronts in regular medium (14 to 17%), and was lowest
in the YRW treatment (6 to 7%). The percentage of n-3
polyunsaturated fatty acids (PUFAs) was much lower in
the lipid-free medium treatment (0.8 to 09% or < 0.2%)
than in the regular medium and YRW treatments (both
3.2 to 4.5%). The surviving meronts in YRW maintained
a relatively similar weight % fatty acid profile as those
at Day 0 (initial). The fatty acid 18:1(n-9), precursor of
20:4(n-6), was abundant in all treatments. However,
only meronts in YRW maintained consistently levels of
this fatty acid similar to the initial (34 to 35%) over time.

RM

Day 14
LF

3.7 ± 0.1
2.0 ± 0.1
11.5 ± 0.1
9.1 ± 0.4
1.2 ± 0.0
0.7 ± 0.0
6.2 ± 0.1
3.6 ± 0.0
31.6 ± 0.3 34.5 ± 0.8
1.9 ± 0.0
1.1 ± 0.0
3.0 ± 0.1
4.2 ± 0.1
6.1 ± 0.2
5.5 ± 0.3
15.0 ± 0.2 22.1 ± 0.1
2.6 ± 0.0
0.9 ± 0.0
0.5 ± 0.0
nd
5.0 ± 0.1
6.2 ± 0.5

YRW
5.1 ± 1.3
12.9 ± 1.2
3.3 ± 0.0
5.3 ± 1.0
34.8 ± 2.5
4.5 ± 0.2
3.4 ± 0.2
7.1 ± 0.6
7.0 ± 0.3
3.4 ± 0.2
1.2 ± 0.2
3.1 ± 0.1

number increased compared to initial values, while
those maintained in YRW decreased over time due to
declining cell numbers (Table 2). The increase in 16:0,
18:0, 18:1(n-9) and 20:4(n-6) was particularly obvious
in meronts cultured in regular medium. Similarly, total
saturated, mono-unsaturated, n-3 and n-6 fatty acids
and total fatty acids increased with increasing meront
number in regular and lipid-free media, whereas all in
YRW decreased. However, the increase in the culture
in lipid-free medium began to level off after Day 7.

Expt 2A. Infectivity of meronts in host-free
environment
All treatment groups except the negative controls
contained oysters with Perkinsus marinus infection
(Table 3, Fig. 5). Prevalence of infection ranged from
80 to 100% and no infection was detected in negative
controls. The oysters inoculated with meronts previously maintained in ASW for 7 d had the highest
infection prevalence (100%). The oysters inoculated
with viable meront cells that had just been transferred
to ASW had significantly lower prevalence (p < 0.05)
than those inoculated with viable 7 d ASW-incubated
meronts. All infections in oysters were light. Average
infection intensities were 59 ± 83, 299 ± 512 and 5767 ±
1190 cells g –1 wet tissue in oysters inoculated with
meronts kept in ASW for 0, 2 and 7 d, respectively.

Individual fatty acid content in cultures
The masses (µg) of all major fatty acids differed significantly (p < 0.05) between treatments, but 16:0, 16:1
(n-7), 18:0, 18:1(n-7), 18:2(n-6) and 22:1(n-9) did not
vary significantly with sampling day (Table 2). Individual fatty acid contents in meronts maintained in regular and lipid-free media increased as the meront cell

Expt 2B. Infectivity of meronts in host-free
environment
Results were similar to those of Expt 2A, with 100%
infection prevalence in oysters inoculated with meronts
that had been kept in ASW for 7 d, while significantly (p

136

Dis Aquat Org 71: 131–139, 2006

Table 2. Perkinsus marinus. Fatty acid content (µg, mean ± SD, n = 3) of meront cells in cultures (10 ml) maintained in regular
medium, lipid-free medium and filtered York River water for 14 d (Expt 1B). Only fatty acids comprising > 2% of total fatty acids
are shown. Sat: total saturated fatty acids; Mono: total mono-unsaturated fatty acids; n-3: total n-3 unsaturated fatty acids; n-6:
total n-6 unsaturated fatty acids; Total: total fatty acids; other abbreviations as in Table 1. a: Significantly different for ‘treatment’
(p < 0.05); b: significantly different for ‘day’ (p < 0.05)
FAME

Day 0
(initial)

Day 3
LF

YRW

RM

Day 7
LF

YRW

RM

Day 14
LF

12.4 ± 0.9
28.7 ± 2.0
4.5 ± 0.3
14.8 ± 1.5
49.3 ± 3.5
6.0 ± 0.4
8.9 ± 0.5
12.0 ± 0.8
36.3 ± 1.0
6.0 ± 0.1
1.6 ± 0.2
11.0 ± 0.2

6.8 ± 0.8
18.6 ± 1.8
1.6 ± 0.1
10.8 ± 1.0
38.1 ± 3.3
2.5 ± 0.2
7.7 ± 0.5
9.4 ± 0.8
33.8 ± 4.0
1.5 ± 0.2
Trace
9.2 ± 0.4

1.7 ± 0.4
3.0 ± 0.7
0.8 ± 0.2
1.3 ± 0.3
7.3 ± 1.7
0.9 ± 0.2
0.7 ± 0.2
1.6 ± 0.4
1.3 ± 0.3
0.6 ± 0.1
Trace
0.5 ± 0.1

12.4 ± 0.6
32.1 ± 0.9
3.8 ± 0.1
21.9 ± 0.3
80.0 ± 2.3
5.9 ± 0.1
8.1 ± 0.2
20.7 ± 0.3
40.0 ± 0.4
6.7 ± 0.2
2.4 ± 0.3
14.0 ± 0.6

6.0 ± 0.5
18.9 ± 1.1
1.6 ± 0.1
10.4 ± 0.5
66.0 ± 3.4
2.5 ± 0.1
8.2 ± 0.4
15.5 ± 0.5
40.7 ± 2.1
1.7 ± 0.1
Trace
12.6 ± 0.4

1.5 ± 0.1
2.5 ± 0.1
0.7 ± 0.0
1.0 ± 0.0
6.4 ± 0.1
0.8 ± 0.0
0.6 ± 0.0
1.2 ± 0.0
1.1 ± 0.0
0.6 ± 0.0
Trace
0.6 ± 0.0

11.2 ± 0.4
35.3 ± 1.5
3.6 ± 0.1
18.9 ± 1.2
96.9 ± 4.0
5.9 ± 0.3
9.3 ± 0.3
18.8 ± 1.5
46.1 ± 2.8
7.9 ± 0.2
1.6 ± 0.1
15.3 ± 0.9

3.8 ± 0.5
17.1 ± 2.3
1.3 ± 0.2
6.8 ± 0.6
64.9 ± 7.8
2.1 ± 0.3
7.8 ± 0.9
10.3 ± 0.7
41.5 ± 4.2
1.7 ± 0.2
Trace
11.7 ± 0.6

0.9 ± 0.3
2.4 ± 0.3
0.6 ± 0.0
1.0 ± 0.2
6.4 ± 0.3
0.8 ± 0.0
0.6 ± 0.0
1.3 ± 0.1
1.3 ± 0.1
0.6 ± 0.1
0.2 ± 0.0
0.6 ± 0.0

Sat ab
Mono ab
n-3 ab
n-6 ab

15.24 73.0 ± 5.0
29.05 80.1 ± 6.1
2.51
9.9 ± 0.2
4.80 51.0 ± 1.7

50.7 ± 4.3
56.1 ± 4.9
1.5 ± 0.2
46.2 ± 4.9

6.8 ± 1.4 93.9 ± 1.2
11.2 ± 2.6 120.2 ± 2.5
0.9 ± 0.1 10.8 ± 0.1
2.0 ± 0.4 54.5 ± 0.7

55.8 ± 2.8
91.7 ± 4.4
1.7 ± 0.1
54.2 ± 2.8

5.8 ± 0.2 94.0 ± 4.7
9.6 ± 0.3 135.2 ± 6.4
0.8 ± 0.0 11.4 ± 0.4
1.8 ± 0.0 62.1 ± 3.6

46.4 ± 4.5
84.1 ± 9.1
1.7 ± 0.2
53.4 ± 5.2

5.5 ± 0.8
9.7 ± 0.5
0.9 ± 0.1
1.9 ± 0.1

Total ab

52.2

14:0 ab
3.4
5.7
16:0 a
16:1(n-7)a
1.7
3.4
18:0 a
18:1(n-9)ab 17.5
18:1(n-7)a
2.4
1.4
18:2(n-6)a
20:1(n-9)ab 5.0
20:4(n-6)ab 3.4
20:5(n-3)ab 1.7
1.1
22:1(n-9)a
1.3
24:0 ab

RM

YRW

216.0 ± 13.2 156.5 ± 13.6 21.4 ± 4.6 283.3 ± 3.8 206.9 ± 10.2 18.2 ± 0.4 306.5 ± 15.3 188.2 ± 19.4 18.4 ± 1.0

< 0.05) fewer oysters were infected in the group injected with meronts that had not been kept in ASW and
in the treatment injected with meronts that had been in
ASW for 3 d, (62 and 48%, respectively) (Fig. 6). However, unlike Expt 2A, 1 oyster was detected with 3
Perkinsus marinus cells g –1 wet tissue in the negative
control (Fig. 6). Average infection intensities were 23 ±
35, 15 ± 18 and 316 ± 560 cells g –1 wet tissue weight in
the treatments inoculated with meronts kept in ASW for
0, 3 and 7 d, respectively (Table 3).
Low mortality was noted in both Expts 2A and B:
1 oyster was found dead in the treatment group in-

oculated with meronts incubated in ASW for 2 d in
Expt 2A, and 1 death occurred in the treatment injected
with meronts incubated in ASW for 7 d in Expt 2B.

DISCUSSION

Perkinsus marinus is transmitted between oysters via
water-borne infective cells (Ray 1954, Mackin 1962,
Andrews 1988, Volety & Chu 1994, Ragone Calvo et al.
2003). While cells released from degraded tissues of
infected dead oysters are the primary source of infective cells for P. marinus transmission (Mackin
1962, Andrews 1988, Ragone Calvo et al.
Table 3. Crassostrea virginica infected by Perkinsus marinus. Parasite
density (mean ± SD; n = 21 oysters in each incubation period) in oysters
2003), dispersion of infective cells via feces
experimentally infected with viable P. marinus meront cells incubated
and pseudo-feces may also be sources of
in artificial seawater (ASW) for 0, 2 or 7 d (Expt 2A) and for 0, 3 or 7 d
infective particles (Bushek et al. 2002). Infec(Expt 2B). Average intensities calculated for infected oysters only. No
tive cells released from a host during summer
P. marinus infection was detected in any oyster in the control group in
(the period during which disease prevalence
Expt 2A; 1 oyster in control treatment was infected with 3 cells g –1
wet tissue wt in Expt 2B
and intensity peak) are believed to be able to
survive in the water column through the winter and are infective when they enter a new
Days incubated in ASW
Day 0
2d
3d
7d
host in the following spring (Mackin 1962).
(initial)
Our study is the first to investigate how long
the primary transmission stage, meront,
Mean density (cells g –1 wet tissue wt)
Expt 2A
59 ± 83
299 ± 512
767 ± 1190
remains viable in the water column and
Expt 2B
23 ± 35
15 ± 18
316 ± 560
whether or not the ‘viable’ meronts are infecRange
tive. Our results show that viable meronts
Expt 2A
2 – 278
3 – 1770
8 – 3795
remained infective in ASW at least for 7 d.
Expt 2B
3 – 110
3 – 63
4 – 1864
Meronts kept in lipid-free medium for 14 d

% of infected oysters
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Fig. 5. Crassostrea virginica infected by Perkinsus marinus.
P. marinus prevalence (% infected oysters, Mean ± SD, Expt
2A) in oysters inoculated with 100 µl of artificial seawater
(ASW) containing 1.5 × 106 viable P. marinus cells that had
been incubated in ASW for 0, 2 or 7 d (n = 21 oysters per
incubation period). Control (–): negative control, oysters inoculated with 100 µl ASW. Different letters denote significant
differences between treatments (p < 0.05)

120
c

100
b

80

b

60
40
20
0

a
Control (–)

0 days

3 days

7 days

Days in ASW prior to injection to oysters
Fig. 6. Crassostrea virginica infected by Perkinsus marinus.
P. marinus prevalence (% infected oysters, Mean ± SD, Expt
2B) in oysters inoculated with 100 µl ASW containing 4.0 × 106
viable P. marinus cells that had been incubated in ASW for
0, 3 or 7 d (n = 21 oysters per incubation period). Further
details as in Fig. 5

retained their ability to synthesize fatty acids, including arachidonic acid [20:4(n-6)]. The fatty acid synthetic ability of meronts in lipid-free medium may be
related to disease transmission processes.
In addition to temperature and salinity, the in situ
concentration of Perkinsus marinus meronts is critical
for disease transmission and development (Volety &
Chu 1994, Chu 1996, Chu & Volety 1997, Ragone Calvo et al. 2003). Dose-dependent transmission of various
P. marinus life stages has been demonstrated in laboratory experiments (Volety & Chu 1994). In a study investigating P. marinus transmission in oysters in relation to
water temperature, oyster mortality and water column
abundance of anti-P. marinus antibody-labeled cells
enumerated by flow cytometry, it was noted that peak
P. marinus infection acquisition coincided with elevated abundance of water-borne P. marinus cells and
was highest at the time of maximum cell abundance
(Ragone Calvo et al. 2003). However, a significant relationship between cell abundance and infection-acqui-
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sition rate was not observed. Ragone Calvo et al. (2003)
speculated that the insignificant correlation between
cell abundance and infection incidence was because
(1) the enumerated cells were not equally infective
and/or (2) through cross-reaction of anti-P. marinus
antibody with other microbes. It is also possible that
not all the enumerated cells were viable, since the viability of the immuno-stained cells was not determined.
Our results revealed heavy mortality in meronts as
soon as they were transferred to YRW. Viability was
reduced from an initial value of nearly 100 to 7.8% at
Day 3 and 6.1% at Day 14. However, those meronts
that did survive the initial high mortality were still
viable after 14 d. Also, although some mortality occurred in meronts maintained in lipid-free medium, the
surviving viable meronts were capable of replicating
(Figs. 1 & 3), and survived for a relatively long time
(24 d, Fig. 3).
In the present study, oysters were experimentally
infected with similar doses of surviving/viable meronts. Apparently viable Perkinsus marinus meronts
are infective for at least 7 d in ASW outside the host.
Higher P. marinus infection prevalence (100%) in the
treatment inoculated with meronts that had been kept
in ASW for 7 d is particularly interesting, although difficult to interpret. One possible explanation is that it
takes time for the parasites from one environment (culture medium) to adjust to a new environment (ASW).
The initial high mortality in meronts kept in YRW and
in meronts maintained in lipid-free medium supports
this. If it is assumed that the culture medium environment is a simulation of the host condition, then one
would expect that heavy mortality would occur when
meronts become host-disassociated, i.e. released to the
water column via decaying of dead infected oyster tissues and/or feces and pseudo-feces. Possibly, those
surviving can remain viable in the water column (i.e.
ASW in the present study) for a long time and have
‘physiologically adapted’ to the new environment.
In the present study, infectivity was tested in
meronts held in ASW up to only 7 d. We believe that infectivity of meronts in nature may well persist beyond
7 d. In the present study, after initial mortality, meronts
in lipid-free medium and YRW survived for up to 24
and 14 d, respectively (Fig. 2). As indicated in the
‘Introduction’, although potential transmission vectors
and reservoirs for Perkinsus marinus have been proposed (Andrew & Hewatt 1957, Hoese 1963, White et
al. 1987), no secondary host has been reported and its
host is a benthic sedentary bivalve Crassostrea virginica. Thus, P. marinus infective cells such as meronts
probably rely mainly on water and tidal currents to
reach distant host populations. Increased survival time
may result in enhanced dispersal distance of infective
cells.
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That only light infection (Table 3) was noted in oysters
in all treatment groups after 9 wk of meront injection
is not surprising since cultured meront cells are usually
less infective or virulent than wild meront cells isolated
from infected oysters (Bushek et al. 1994a, Chintala et
al. 2002, Ford et al. 2002). The single infection in the
control group probably originated from Maine.
Fatty acid synthetic activity continued, with a slight
increase in 18:1(1n-9) and 20:4(n-6) in meronts maintained in lipid-free medium. The decrease of fatty acid
content in those meronts maintained in YRW was due
to heavy mortality, which resulted in reduction in cell
numbers. This suggests that the nutrients in YRW cannot sustain fatty acids and lipid synthesis, thus prohibiting proliferation, although the survivors managed
to maintain a fatty acid profile similar to that of the
inoculum. The lipid-free medium consists of many
small components such as amino acids, vitamins and
sugars. In nature, there is dissolved organic matter
(DOM) comprised of similar molecules including free
amino acids, monosaccharides and short chain, free
fatty acids. Although most of these are refractory, there
is considerable evidence that many microbes, filter
feeders and larval and juvenile fishes consume them
for energy, particularly at times of food limitation
(Manahan 1983, Feral 1985, Korsgaard 1991, Diaz et
al. 1994, Otake et al. 1995, Kragh & Sondergaard
2004). The infectivity shown by meronts maintained in
ASW for 7 d was surprising, since ASW contains only
inorganic salts. With this in mind, it is conceivable that
meront cells can live in the water column for days, if
not weeks, until an opportunity for reinfection arises.
Hyponospores of Perkinsus marinus can tolerate temperatures as low as 4°C for 4 to 7 d (Chu & Greene
1989), and within oyster tissues hyponospores remained viable after freezing (Andrew & Hewatt 1957).
Thus, the suggestion that P. marinus may survive over
the winter outside its host and reinfect oysters the following spring (Mackin 1962) is supportable. However,
a time frame of several months outside the host may be
too long a period for the parasite to survive without the
essential nutrient supply derived from the host environment, especially since DOM availability and concentration are seasonally variable. We found high cell
mortality in P. marinus meront cell culture at the stationary phase in regular media. Cell viability dropped
below 40% in 28 d old cultures and ranged from 11 to
25% between 38 and 47 d old cultures (Soudant et al.
2005). Thus, in addition to low temperature and
salinity, nutrient availability could be a limiting factor
for P. marinus distribution.
The heavy mortality in Perkinsus marinus at the stationary phase and beyond may be due to limitation of
sterols. Sterols are essential structural components in
addition to phospholipids and long chain polyunsatu-

rated fatty acids. Thus far, only parasitic protozoans of
the family Trypanosomatidae have been reported to
have the ability of synthesizing sterols (Contreras et al.
1997, Lepesheva et al. 2004). Although P. marinus has
a greater fatty acid synthetic ability than other parasitic protozoans (Chu et al. 2002), it must acquire
sterols from its host for survival and membrane synthesis. We have found that meronts proliferate in medium
with cholesterol as the only lipid source (unpubl. obs.).
P. marinus meronts are also incapable of synthesizing
n-3 fatty acids (Soudant & Chu 2001, Chu et al. 2002).
The increase in n-3 long chain fatty acids such as
20:5(n-3) and 22:6(n-3) in meronts grown in regular
medium is due to incorporation and assimilation rather
than de novo synthesis.
In summary, the present study has demonstrated that
although heavy mortality occurred when in vitro cultured meronts were transferred to estuarine water (i.e.
YRW), the survivors remained viable for up to 14 d.
Despite some mortality in meronts maintained in lipidfree medium, those that survived were able to replicate and their fatty acid synthetic ability continued.
Viable meronts that had been kept in ASW for 2, 3 or
7 d were infective. The highest Perkinsus marinus
prevalence (100%) was in the oysters inoculated with
meronts that had been kept in ASW for 7 d. These
results suggest that P. marinus meront cells can survive
for at least 14 d in the water column and that viable
meronts remain infective for at least 7 d. However, the
present study was conducted using in vitro cultured
meront cells, which could differ greatly from wild
meronts in terms of survival and infectivity. Future
studies should be directed at testing the viability and
infectivity of wild meronts freshly isolated from infected oyster tissues, and should extend the length of
incubation time in water for longer than 7 d.
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